Meanwhile, these percentages of CD62L, CD54 and CD94 on NK cells in GPB were not only significantly increased compared with those on NK cells in NGPB but also increased compared to those on NK cells in GBM (Figure 1E‐G). This evidence concerns the gene SELL and glioblastoma.